Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Cost-minimisation analysis (CMA)
A form of economic evaluation comparing the costs of alternative interventions that have equal effects.
In Health care, Cost-minimisation analysis (CMA) is an economic appraisal that determines the least costly alternative therapy after the proposed drug has been established to be no more detrimental than its main competitor(s) in terms of capability and toxicity.
See also:
Cost–benefit analysis
Cost-effective (healthcare economics)
Cost-effectiveness league table (healthcare economics)
Cost-effectiveness threshold (health economics)
Cost consequences analysis (CCA)
Related terms
Sensitivity to change (pharmacoeconomics), Cost per acquisition/action (CPA) , Australian Medical Association (AMA), Utility weighted index, Internal communications, Cost-effectiveness analysis (health economics), Secondary care, Off-label use, Competitor analysis, National Institute for Health and Clinical Excellence , Phase III trials, Foundation Trust (FT), Quality assurance programme, Compassionate use, Cost-effectiveness (in media/advertising),
Featured jobs
-
Vice President
-
Competitive Salary Offered
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Consultant
-
competitive salary
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Account Director or Senior Account Director
-
Salary TBC
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
Subscribe to our email news alerts
- Lilly will aim for one $1bn-$5bn deal per quarter in 2020
- Novartis links up with NHS for speedy access to cholesterol drug inclisiran
- NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi
- Immuno-oncology, personalised medicine continues to drive pharma sector
- FDA delays decision on Intercept's NASH drug by three months
- Novartis gets EU approval for multiple sclerosis therapy Mayzent
- New coronavirus sees drug developers scramble to develop a vaccine
- Sanofi completes acquisition of immuno-oncology specialist Synthorx
- Roche's checkpoint inhibitor fails pivotal urothelial cancer trial
- Epizyme wins FDA approval for epithelioid sarcoma treatment
- Pharma Brand Planners' Blog (Part 8)
- Happy Chinese New Year 2020 - The Year of The Rat
PMHub
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...
Quick links
Infographics
